Literature DB >> 21541507

Expression of prothymosin-alpha and c-myc mRNA in human gastric cancer.

K Shibuta1, M Mori, K Mimori, H Inoue, H Nakashima, K Baba, M Haraguchi, N Karimine, H Ueo, T Akiyoshi.   

Abstract

Prothymosin-alpha (PT-alpha) is a nuclear protein involved in cell proliferation. c-myc is implicated in the carcinogenesis of many human cancers. PT-alpha gene transcription is reported to be regulated by the c-myc gene in vitro. However, little has been reported on the PT-alpha and c-myc mRNA expressions in gastric cancer. We semi-quantitatively determined the PT-alpha and c-myc mRNA expressions in 60 pairs of gastric cancer tissue (T) and corresponding normal tissue (N) using the reverse transcriptase-polymerase chain reaction method. The average of T/N ratio was 1.20 for PT-alpha and 1.30 for c-myc. Cases demonstrating a T/N ratio of more than 1.0 were seen in 33 (55%) and 30 (50%) cases for PT-alpha and c-myc, respectively. No significant correlation was observed between either of these two mRNA expressions and any of the examined clinicopathologic factors for gastric cancer. However, a significant correlation was seen between the expressions of both genes (p<0.0001). The findings support the hypothesis that, regarding human gastric cancer, the transcription of PT-alpha is considered to be under the control of c-myc gene, however, the value of these gene expressions do not reflect biological behavior.

Entities:  

Year:  1996        PMID: 21541507     DOI: 10.3892/ijo.9.2.247

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  2 in total

1.  MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells.

Authors:  Ning Xu; Zimu Li; Zhange Yu; Feng Yan; Yang Liu; Xiaofeng Lu; Weiliang Yang
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

2.  Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells.

Authors:  Yi-Te Lin; Chuck C-K Chao
Journal:  Oncotarget       Date:  2015-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.